Clincosm LogoSign in Get a demo

Advanced Pancreatic Cancer

Showing 1 - 25 of 41
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Pancreatic Cancer Trial in Shanghai (Pimicotinib (ABSK021))

Recruiting
  • Advanced Pancreatic Cancer
  • Pimicotinib (ABSK021)
  • Shanghai, Shanghai, China
    Renji Hospital Affiliated to Shanghai Jiaotong University School
Oct 26, 2023

Advanced Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Modena (Olaparib 150 MG)

Recruiting
  • Advanced Pancreatic Cancer
  • Metastatic Pancreatic Cancer
  • Olaparib 150 MG
  • Modena, Italy
    Aou Modena
Oct 5, 2023

Advanced Pancreatic Cancer Trial in Qionghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Pancreatic Cancer
  • Personalized neoantigen tumor vaccine
  • Qionghai, Hainan, China
    Ruijin-Hainan Hospital Affiliated to Shanghai Jiao Tong Universi
Jun 14, 2023

Pancreatic Cancer, Pancreas Adenocarcinoma, Advanced Pancreatic Cancer Trial in United States (Pembrolizumab, paricalcitol, )

Completed
Has Results
  • Pancreatic Cancer
  • +4 more
  • Scottsdale, Arizona
  • +5 more
Dec 1, 2022

Advanced Pancreatic Cancer Trial in Shanghai (JS107, JS107 combination with Toripalimab)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • JS107
  • JS107 combination with Toripalimab
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 19, 2022

Advanced Pancreatic Cancer Trial in Shanghai (CT-707, Toripalimab, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Oct 17, 2022

Advanced Pancreatic Cancer, Solid Tumor Malignancies Trial run by the (ProAgio)

Recruiting
  • Advanced Pancreatic Cancer
  • Solid Tumor Malignancies
  • Bethesda, Maryland
    National Cancer Institute
Sep 26, 2022

Advanced Pancreatic Cancer Trial in Shanghai (Chemotherapy guided by organoid drug sensitivity test)

Recruiting
  • Advanced Pancreatic Cancer
  • Chemotherapy guided by organoid drug sensitivity test
  • Shanghai, China
    Changhai Hospital
Jul 29, 2022

Metastatic Pancreatic Cancer, Advanced Pancreatic Cancer Trial in Lyon (Tumor samples (archival FFPE) and blood samples)

Recruiting
  • Metastatic Pancreatic Cancer
  • Advanced Pancreatic Cancer
  • Tumor samples (archival FFPE) and blood samples
  • Lyon, France
    Centre Léon Bérard
Jul 21, 2022

Advanced Pancreatic Cancer Trial in Nanjing (Adoptive TIL-TCM transfer therapy)

Recruiting
  • Advanced Pancreatic Cancer
  • Adoptive TIL-TCM transfer therapy
  • Nanjing, Jiangsu, China
    Jinling Hospital
Jun 29, 2022

Advanced Pancreatic Cancer Trial in Worldwide (Cabiralizumab, Nab-paclitaxel, Onivyde)

Active, not recruiting
  • Advanced Pancreatic Cancer
  • Cabiralizumab
  • +8 more
  • Phoenix, Arizona
  • +40 more
Apr 6, 2022

Advanced Pancreatic Cancer Trial in Xuzhou (Envafolimab, Endostar, Nab paclitaxel)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Xuzhou, Jiangsu, China
    The Affiliated Hospital of Xuzhou Medical University
Mar 18, 2022

Advanced Pancreatic Cancer Trial in Baltimore (galeterone, Gemcitabine)

Recruiting
  • Advanced Pancreatic Cancer
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 10, 2022

Advanced Pancreatic Cancer Trial in Hangzhou (Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in

Recruiting
  • Advanced Pancreatic Cancer
  • Recombinant Human IL12/15-PDL1B Oncolytic HSV-1 Injection (Vero Cell)) in combination with Nivolumab
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, School of Medicine, Zhejiang Univ
Mar 8, 2022

Advanced Pancreatic Cancer Trial in Shanghai (APG-1387 for Injection, Gemcitabine, Nab paclitaxel)

Recruiting
  • Advanced Pancreatic Cancer
  • APG-1387 for Injection
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jan 26, 2022

Advanced Pancreatic Cancer Trial in Beijing (Irinotecan liposome;oxaliplatin;5-FU(Fluorouracil Injection);LV(Calcium Folinate

Enrolling by invitation
  • Advanced Pancreatic Cancer
  • Irinotecan liposome；oxaliplatin；5-FU(Fluorouracil Injection)；LV(Calcium Folinate Injection)
  • Beijing, Beijing, China
    Peking Union Medical College Hospital
Jan 17, 2022

Advanced Hepatocellular Carcinoma, Advanced Colorectal Cancer, Advanced Gastric Cancer Trial in Hangzhou (EPCAM CAR-T)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • +3 more
  • EPCAM CAR-T
  • Hangzhou, China
    First affiliated hospital, School of Medicine, Zhejiang Universi
Jan 12, 2022

Advanced Pancreatic Cancer Trial in Ireland (Paricalcitol, Gemcitabine (GEM) and Nab-paclitaxel)

Active, not recruiting
  • Advanced Pancreatic Cancer
  • Dublin, Dublin 24, Ireland
  • +5 more
Nov 11, 2021

Advanced Pancreatic Cancer, Advanced Solid Tumor Trial in Toledo (Metformin, Simvastatin, Digoxin)

Recruiting
  • Advanced Pancreatic Cancer
  • Advanced Solid Tumor
  • Toledo, Ohio
    University of Toledo, Eleanor N. Dana Cancer Center
Nov 16, 2021

Advanced Pancreatic Cancer Trial in Worldwide (IMM-101, Gemcitabine)

Completed
Has Results
  • Advanced Pancreatic Cancer
  • Nicosia, Strovolos, Cyprus
  • +20 more
Nov 3, 2021

Advanced Pancreatic Cancer Trial (Mitoxantrone Hydrochloride Liposome injection)

Not yet recruiting
  • Advanced Pancreatic Cancer
  • Mitoxantrone Hydrochloride Liposome injection
  • (no location specified)
Oct 19, 2021

Information Tool for People With Advanced Pancreatic Cancer

Completed
  • Advanced Pancreatic Cancer
  • web-based interactive tool
  • Bournemouth, United Kingdom
  • +3 more
Oct 7, 2021

Pancreatic Cancer, Advanced Pancreatic Cancer, Pancreatic Adenocarcinoma Trial in New York, Charlottesville

Active, not recruiting
  • Pancreatic Cancer
  • +3 more
  • anti-EGFR-bispecific antibody armed activated T-cells
  • New York, New York
  • +1 more
Oct 7, 2021

Advanced Pancreatic Cancer Trial in Shanghai (SHR-A1904)

Recruiting
  • Advanced Pancreatic Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 18, 2021

Anlotinib, Anti-PD-1 Antibody, Advanced Pancreatic Cancer Trial in Beijing (Anlotinib plus AK105)

Not yet recruiting
  • Anlotinib
  • +2 more
  • Anlotinib plus AK105
  • Beijing, Beijing, China
    Department of Medical Oncology, Peking Union Medical College Hos
Mar 16, 2021